Covaxin safe for kids aged 2-18, found as effective as in adults: Lancet

The data were submitted to India's Central Drugs Standard Control Organisation in October 2021 and the vaccine has received its approval for emergency use in children aged 6-18 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Kvhrsb3
via IFTTT